While there is evidence linking ApoE4 to cognitive deficits, morphological, structural, and functional brain alterations during AD progression (Cherbuin et al., 2007; Liu et al., 2013), at this point, it is still unclear how this genetic risk factor affects the organization of brain networks. This evidence concerns the gene APOE and Alzheimer disease.